Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Edward Pershing currently holds 2,613,807 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward Pershing has been a net buyer of PVCT stock. They have purchased $329.8K and sold $0 worth of shares.
Edward Pershing's most recent insider trade was on Mar 25, 2026, when they sold 0 shares at $0.00 per share.
Edward Pershing serves as Executive at PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT). They have executed 53 insider transactions totaling $329.8K over their tenure at the company.
Edward Pershing holds the position of Executive at PROVECTUS BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Edward Pershing has shown a buying trading pattern, with $329.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Edward Pershing was on Nov 22, 2024, when they purchased $229.8K worth of PVCT shares. This transaction involved 80,365 shares at $2.86 per share.
Edward Pershing currently owns 2,613,807 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Edward Pershing's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Edward Pershing has 53 Form 4 filings on record as an insider at PROVECTUS BIOPHARMACEUTICALS, INC..
Set alerts for Edward Pershing and 40,000+ other insiders.